Large-Scale Identification of Disease Genes Involved in Acute Myeloid Leukemia

Journal of Virology

Volumn 78, Issue 4, 2004, Pages 1971-1980

  Erkeland, Stefan J ^a   Valkhof, Marijke ^a   Heijmans Antonissen, Claudia ^a   Van Hoven Beijen, Antoinette ^a   Delwel, Ruud ^a   Hermans, Mirjam H A ^a   Touw, Ivo P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMOSOME ABERRATION; COMMON INTEGRATION SITE; CONTROLLED STUDY; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GENE SEQUENCE; GENETIC DISORDER; LYMPHOMA; MONOCYTIC LEUKEMIA; MOUSE; MURINE LEUKEMIA VIRUS; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; RETROVIRUS; STRAIN IDENTIFICATION; UNINDEXED SEQUENCE; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTANT; VIRUS PATHOGENESIS;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID; MICE; MUTAGENESIS, INSERTIONAL; PROTEINS; PROVIRUSES; RETROVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 0842347703     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.4.1971-1980.2004     Document Type: Article

References (65)

1. Adler, H. T., P. J. Reynolds, C. M. Kelley, and B. M. Sefton. 1988. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters. J. Virol. 62:4113-4122.
2. An, S., Y. Zheng, and T. Bleu. 2000. Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J. Biol. Chem. 275:288-296.
3. Aoki, N., and T. Matsuda. 2000. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J. Biol. Chem. 275:39718-39726.
4. Ben David, Y., E. B. Giddens, and A. Bernstein. 1990. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci., USA 87:1332-1336.
5. Buchberg, A. M., H. G. Bedigian, N. A. Jenkins, and N. G. Copeland. 1990. Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol. Cell. Biol. 10:4658-4666.
6. Butterfield, L. H., A. Merino, S. H. Golub, and H. Shau. 1999. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid. Redox Signal. 1:385-402.
7. Coggeshall, K. M., K. Nakamura, and H. Phee. 2002. How do inhibitory phosphatases work? Mol. Immunol. 39:521-529.
8. Denicourt, C., E. Edouard, and E. Rassart. 1999. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration. J. Virol. 73:4439-4442.
9. Erkeland, S. J., M. Valkhof, C. Heijmans-Antonissen, R. Delwel, P. J. Valk, M. H. Hermans, and I. P. Touw. 2003. The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 101:1111-1117.
10. Frasch, S. C., J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen, and P. M. Henson. 1998. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:8389-8397.
11. Garvin, A. M., S. Pawar, J. D. Marth, and R. M. Perlmutter. 1988. Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line. Mol. Cell. Biol. 8:3058-3064.
12. Girard, L., Z. Hanna, N. Beaulieu, C. D. Hoemann, C. Simard, C. A. Kozak, and P. Jolicoeur. 1996. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev. 10:1930-1944.
13. Girard, L., and P. Jolicoeur. 1998. A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV(D)/myc transgenic mice. Oncogene 16:517-522.
14. Grimwade, D., H. Walker, G. Harrison, F. Oliver, S. Chatters, C. J. Harrison, K. Wheatley, A. K. Burnett, and A. H. Goldstone. 2001. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312-1320.
15. Grimwade, D., H. Walker, F. Oliver, K. Wheatley, C. Harrison, G. Harrison, J. Rees, I. Hann, R. Stevens, A. Burnett, A. Goldstone, et al. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322-2333.
16. Haj, F. G., B. Markova, L. D. Klaman, F. D. Bohmer, and B. G. Neel. 2003. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J. Biol. Chem. 278:739-744.
17. Hellsten, E., J. P. Evans, D. J. Bernard, P. A. Janne, and R. L. Nussbaum. 2001. Disrupted sperm function and fertilin beta processing in mice deficient in the inositol polyphosphate 5-phosphatase Inpp5b. Dev. Biol. 240:641-653.
18. Hirvonen, H., V. Hukkanen, T. T. Salmi, T. T. Pelliniemi, and R. Alitalo. 1993. L-myc and N-myc in hematopoietic malignancies. Leuk. Lymphoma 11:197-205.
19. Hogenesch, J. B., K. A. Ching, S. Batalov, A. I. Su, J. R. Walker, Y. Zhou, S. A. Kay, P. G. Schultz, and M. P. Cooke. 2001. A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell 106:413-415.
20. Hubbard, T., D. Barker, E. Birney, G. Cameron, Y. Chen, L. Clark, T. Cox, J. Cuff, V. Curwen, T. Down, R. Durbin, E. Eyras, J. Gilbert, M. Hammond, L. Huminiecki, A. Kasprzyk, H. Lehvaslaiho, P. Lijnzaad, C. Melsopp, E. Mongin, R. Pettett, M. Pocock, S. Potter, A. Rust, E. Schmidt, S. Searle, G. Slater, J. Smith, W. Spooner, A. Stabenau, J. Stalker, E. Stupka, A. Ureta-Vidal, I. Vastrik, and M. Clamp. 2002. The Ensembl genome database project. Nucleic Acids Res. 30:38-41.
21. Hwang, H. C., C. P. Martins, Y. Bronkhorst, E. Randel, A. Berns, M. Fero, and B. E. Clurman. 2002. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc. Natl. Acad. Sci. USA 99:11293-11298.
22. Jansen, J. H., M. C. de Ridder, W. M. Geertsma, C. A. Erpelinck, K. van Lom, E. M. Smit, R. Slater, B. A. van der Reijden, G. E. de Greef, P. Sonneveld, and B. Lowenberg. 1999. Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor. Blood 94:39-45.
23. Jonkers, J., and A. Berns. 1996. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287:29-57.
24. Joosten, M., P. J. Valk, M. A. Jorda, Y. Vankan-Berkhoudt, S. Verbakel, B. M. van den, A. Beijen, B. Lowenberg, and R. Delwel. 2002. Leukemic predisposition of pSca-1/Cb2 transgenic mice. Exp. Hematol. 30:142-149.
25. Joosten, M., P. J. Valk, Y. Vankan, N. de Both, B. Lowenberg, and R. Delwel. 2000. Phenotyping of Evil, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. Virology 268:308-318.
26. Joosten, M., Y. Vankan-Berkhoudt, M. Tas, M. Lunghi, Y. Jenniskens, E. Parganas, P. J. Valk, B. Lowenberg, A. E. van den Akker, and R. Delwel. 2002. Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites. Oncogene 21:7247-7255.
27. Jorda, M. A., B. Lowenberg, and R. Delwel. 2003. The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Blood 101:1336-1343.
28. Junn, E., S. H. Han, J. Y. Im, Y. Yang, E. W. Cho, H. D. Um, D. K. Kim, K. W. Lee, P. L. Han, S. G. Rhee, and I. Choi. 2000. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164:6287-6295.
29. Kerlavage, A., V. Bonazzi, M. di Tommaso, C. Lawrence, P. Li, F. Mayberry, R. Mural, M. Nodell, M. Yandell, J. Zhang, and P. Thomas. 2002. The Celera discovery system. Nucleic Acids Res. 30:129-136.
30. Largaespada, D. A. 2000. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies. Leukemia 14:1174-1184.
31. Lee, J. S., A. Ishimoto, T. Honjo, and S. Yanagawa. 1999. Murine leukemia provirus-mediated activation of the Notch1 gene leads to induction of HES-1 in a mouse T lymphoma cell line, DL-3. FEBS Lett. 455:276-280.
32. Li, J., H. Shen, K. L. Himmel, A. J. Dupuy, D. A. Largaespada, T. Nakamura, J. D. Shaughnessy, Jr., N. A. Jenkins, and N. G. Copeland. 1999. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat. Genet. 23:348-353.
33. Look, A. T. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
34. Lowenberg, B., J. R. Downing, and A. Burnett. 1999. Acute myeloid leukemia. N. Engl. J. Med. 341:1051-1062.
35. a. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
36. Marth, J. D., R. Peet, E. G. Krebs, and R. M. Perlmutter. 1985. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell 43:393-404.
37. Melnick, A. M., J. J. Westendorf, A. Polinger, G. W. Carlile, S. Arai, H. J. Ball, B. Lutterbach, S. W. Hiebert, and J. D. Licht. 2000. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 20:2075-2086.
38. Mikkers, H., and A. Berns. 2003. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88:53-99.
39. Morishita, K., D. S. Parker, M. L. Mucenski, N. A. Jenkins, N. G. Copeland, and J. N. Ihle. 1988. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54:831-840.
40. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314:633-636.
41. Munoz, J. J., C. Tarrega, C. Blanco-Aparicio, and R. Pulido. 2003. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. Biochem. J. 372:193-201.
42. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol. 10:3307-3313.
43. Myers, M. P., J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford, and N. K. Tonks. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276:47771-47774.
44. Nakamura, T., D. A. Largaespada, J. D. Shaughnessy, Jr., N. A. Jenkins, and N. G. Copeland. 1996. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat. Genet. 12:149-153.
45. Neil, J. C., and E. R. Cameron. 2002. Retroviral insertion sites and cancer: fountain of all knowledge? Cancer Cell 2:253-255.
46. Noh, D. Y., S. J. Ahn, R. A. Lee, S. W. Kim, I. A. Park, and H. Z. Chae. 2001. Overexpression of peroxiredoxin in human breast cancer., Anticancer Res. 21:2085-2090.
47. Nordberg, J., and E. S. Arner. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:1287-1312.
48. Pedersen-Bjergaard, J., D. H. Christiansen, M. K. Andersen, and F. Skovby. 2002. Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Leukemia 16:2177-2184.
49. Ru, M., C. Shustik, and E. Rassart. 1993. Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent. J. Virol. 67:4722-4731.
50. Sato, K., N. Murata, J. Kon, H. Tomura, H. Nochi, K. Tamoto, M. Osada, H. Ohta, Y. Tokumitsu, M. Ui, and F. Okajima. 1998. Downregulation of mRNA expression of Edg-3, a putative sphingosine 1-phosphate receptor coupled to Ca2+ signaling, during differentiation of HL-60 leukemia cells. Biochem. Biophys. Res. Commun. 253:253-256.
51. Selten, G., H. T. Cuypers, and A. Berns. 1985. Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J. 4:1793-1798.
52. Setoguchi, M., Y. Higuchi, S. Yoshida, N. Nasu, Y. Miyazaki, S. Akizuki, and S. Yamamoto. 1989. Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids. Mol. Cell. Biol. 9:4515-4522.
53. Shaknovich, R., P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht. 1998. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol. Cell. Biol. 18:5533-5545.
54. Shilatifard, A., W. S. Lane, K. W. Jackson, R. C. Conaway, and J. W. Conaway. 1996. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271:1873-1876.
55. Suzuki, T., H. Shen, K. Akagi, H. C. Morse, J. D. Malley, D. Q. Naiman, N. A. Jenkins, and N. G. Copeland. 2002. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32:166-174. (Erratum, 32:331.)
56. Tan-Pertel, H. T., L. Walker, D. Browning, A. Miyamoto, G. Weinmaster, and J. C. Gasson. 2000. Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J. Immunol. 165:4428-4436.
57. Thirman, M. J., D. A. Levitan, H. Kobayashi, M. C. Simon, and J. D. Rowley. 1994. Cloning of ELL, a gene that fuses to MLL in t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 91:12110-12114.
58. Valk, P. J., and R. Delwel. 1998. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis. Leuk. Lymphoma 32:29-43.
59. Verstovsek, S., E. Estey, T. Manshouri, M. Keating, H. Kantarjian, F. J. Giles, and M. Albitar. 2001. High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome. Leuk. Lymphoma 42:511-516.
60. Verstovsek, S., H. Kantarjian, T. Manshouri, S. O'Brien, S. Faderl, M. Talpaz, J. Cortes, and M. Albitar. 2002. Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer 94:1517-1521.
61. Vyas, P., F. A. Norris, R. Joseph, P. W. Majerus, and S. H. Orkin. 2000. Inositol polyphosphate 4-phosphatase type I regulates cell growth down-stream of transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 97:13696-13701.
62. Wiederschain, D., H. Kawai, J. Gu, A. Shilatifard, and Z. M. Yuan. 2003. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. Mol. Cell. Biol. 23:4230-4246.
63. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 30:1749-1751.
64. Zelent, A., F. Guidez, A. Melnick, S. Waxman, and J. D. Licht. 2001. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 20:7186-7203.
65. Zhang, Z. Y., B. Zhou, and L. Xie. 2002. Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol. Ther. 93:307-317.